Open-label trial on efficacy of artemether/lumefantrine against the uncomplicated Plasmodium falciparum malaria in Metema district, Northwestern Ethiopia

PURPOSE: Following the increased Plasmodium falciparum resistance to chloroquine and sulfadoxine/pyrimethamine, Ethiopia adopted artemether/lumefantrine (AL) as the first-line treatment for uncomplicated P. falciparum in 2004. According to the recommendation of the World Health Organization, this st...

詳細記述

保存先:
書誌詳細
出版年:Ther Clin Risk Manag
主要な著者: Wudneh, Feven, Assefa, Ashenafi, Nega, Desalegn, Mohammed, Hussien, Solomon, Hiwot, Kebede, Tadesse, Woyessa, Adugna, Assefa, Yibeltal, Kebede, Amha, Kassa, Moges
フォーマット: Artigo
言語:Inglês
出版事項: Dove Medical Press 2016
主題:
Original Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5005000/
https://ncbi.nlm.nih.gov/pubmed/27601913
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S113603
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料